Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-002489
Accepted
2023-08-25 00:15:12
Documents
1
Effectiveness Date
2023-08-24
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 593
  Complete submission text file 9999999995-23-002489.txt   1823
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-273961 | Film No.: 231203719
SIC: 2836 Biological Products, (No Diagnostic Substances)